When determining the prognosis in patients undergoing hematopoietic stem cell transplantation (HSCT) for myelodysplastic syndrome (MDS) which risk factors receive 2 points?

Updated: Jul 24, 2018
  • Author: Emmanuel C Besa, MD; Chief Editor: Koyamangalath Krishnan, MD, FRCP, FACP  more...
  • Print
Answer

Risk factors assigned 2 points are as follows:

  • Monosomal karyotype
  • Age 50 years or older

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!